3-(tert-butoxycarbonyl)-1-(hydroxymethyl)-5-nitro-1,2-dihydro-3H-benzindole | 193225-63-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 3-(tert-butoxycarbonyl)-1-(hydroxymethyl)-5-nitro-1,2-dihydro-3H-benzindole
• 英文别名: 1-(hydroxymethyl)-5-nitro-3-(tert-butoxycarbonyl)-1,2-dihydro-3H-benzo[e]indole；tert-butyl 1-(hydroxymethyl)-5-nitro-1H-benzo[e]indole-3(2H)-carboxylate；3-(tert-butyloxycarbonyl)-1-(hydroxymethyl)-5-nitro-1,2-dihydro-3H-benz[e]indole；3-(tert-butyloxycarbonyl)-1-hydroxymethyl-5-nitro,1,2-dihydro-3H-benz[e]indole；tert-butyl 1-(hydroxymethyl)-5-nitro-1,2-dihydrobenzo[e]indole-3-carboxylate
• CAS: 193225-63-7
• 化学式: C₁₈H₂₀N₂O₅
• 分子量: 344.367
• InChiKey: ROOWKMHOADTTRB-UHFFFAOYSA-N

物化性质

• 熔点：
  176 °C
• 沸点：
  500.5±50.0 °C(Predicted)
• 密度：
  1.317±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  95.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-(tert-butoxycarbonyl)-1-(hydroxymethyl)-5-nitro-1,2-dihydro-3H-benzindole 以 吡啶 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 3-(tert-butyloxycarbonyl)-1-(chloromethyl)-5-nitro-1,2-dihydro-3H-benzindole
  参考文献：
  名称：

  Condensed N-aclyindoles as antitumor agents

  摘要：

  该发明提供了一般式(I)的化合物，其中：X是卤素或OSO.sub.2 R，其中R代表H或未取代或羟基或氨基取代的较低烷基；Y是一个硝基或胺基团或其取代衍生物；W从式(Ia、Ib或Ic)的结构中选择，其中E为--N.dbd.或--CH.dbd.，G为O、S或NH，Q为R、OR、NRR、NO.sub.2、CONHR、NHCOR或NHCONHR中的最多三个，或者是式(Ia、Ib或Ic)的附加基团，HET代表一个5-或6-成员的碳环或杂环；A和B共同代表一个融合的苯或2-CO.sub.2 R吡咯环。在一个实施例中，基团Y是由一种基团取代的胺衍生物，该基团是一种硝基还原酶或羧肽酶酶的底物，使得其中一种酶能够去除该基团。

  公开号：

  US06130237A1
• 作为产物：
  描述：

  3-(tert-butoxycarbonyl)-1,1-di(methoxycarbonyl)-5-nitro-1,2-dihydro-3H-benzindole 在 sodium methylate 、 二异丁基氢化铝 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 为溶剂， 反应 1.0h， 生成 3-(tert-butoxycarbonyl)-1-(hydroxymethyl)-5-nitro-1,2-dihydro-3H-benzindole
  参考文献：
  名称：

  Synthesis and Cytotoxicity of 5-Amino-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2- dihydro-3H-benz[e]indole (Amino-seco-CBI-TMI) and Related 5-Alkylamino Analogues:  New DNA Minor Groove Alkylating Agents

  摘要：

  The first synthesis of seco-CBI-TMI alkylating agents with 5-nitrogen substituents is reported. The parent 5-amino compound was prepared in a 15-step synthesis from 1-hydroxynaphthalene-2-carboxylic acid. Reductive alkylation of the 5-amino compound gave the corresponding 5-methylamino and 5-dimethylamino analogues, while resolution of an intermediate by chiral HPLC allowed preparation of the R and S enantiomers of the 5-amino analogue. Absolute configuration was assigned by X-ray crystallography. The S enantiomer was about 65-fold more cytotoxic than the R enantiomer in cell line assays. The 5-amino and 5-methylamino compounds had in vitro cytotoxicities comparable to that of the known 5-hydroxy analogue (0.2-0.5 nM), while the 5-dimethylamino derivative was about 10-fold less potent. The high potencies of the 5-amino and 5-methylamino analogues make them of interest for the formation of relatively stable amine-based prodrugs.

  DOI：

  10.1021/jo981395w

文献信息

• The effect of sulfonate leaving groups on the hypoxia-selective toxicity of nitro analogs of the duocarmycins
  作者：Amir Ashoorzadeh、Graham J. Atwell、Frederik B. Pruijn、William R. Wilson、Moana Tercel、William A. Denny、Ralph J. Stevenson

  DOI：10.1016/j.bmc.2011.06.073

  日期：2011.8

  dol-1-yl)methyl sulfonate (nitroCBI) prodrugs containing sulfonate leaving groups undergo hypoxia-selective metabolism to form potent DNA minor groove alkylating agents. They were evaluated (along with chloride leaving group analogs for comparison) for their cytotoxicity against cultures of SKOV3 and HT29 human tumor cell lines under both aerobic and hypoxic conditions. Sulfonates with neutral side

  一系列含有磺酸盐离去基团的3-取代的（5-硝基-2,3-二氢-1 H-苯并[ e ]吲哚-1-基）甲基磺酸盐（nitroCBI）前药经历缺氧选择性代谢，形成有效的DNA小分子沟槽烷基化剂。评估了它们（与氯离去基团类似物进行比较）在有氧和低氧条件下对SKOV3和HT29人肿瘤细胞系培养物的细胞毒性。具有中性侧链的磺酸盐（例如5,6,7-三甲氧基吲哚； TMI）在SKOV3细胞中显示出始终比相应的氯代类似物（2.8-3.1）更高的低氧细胞毒性比（HCR）（34-246），但是这些趋势确实不适用于带有阳离子或极性中性侧链的化合物。
• Synthesis and cytotoxicity of amino analogues of the potent DNA alkylating agent seco-CBI-TMI
  作者：G.J. Atwell、W.R. Wilson、W.A. Denny

  DOI：10.1016/s0960-894x(97)00259-x

  日期：1997.6

  The synthesis of racemic seco-CBI-TMI analogues containing nitrogen-based groups in place of the 5-OH is reported, employing a synthetic strategy where the incipient C-5 amino substituent is generated in the last step from a nitro precursor. The resulting amino seco-CBI analogues are up to 1000-fold more potent cytotoxins than the corresponding known amino seco-CI compounds, making them attractive candidates as effecters in prodrug strategies. (C) 1997 Elsevier Science Ltd.
• Weight loss effects of quaternary salts of 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indoles; structure–activity relationships
  作者：Moana Tercel、Ralph J. Stevenson、Guo-Liang Lu、Stephen M. Stribbling、William R. Wilson、Michele A. Tatnell、Rebecca N. Marnane、Kathleen G. Mountjoy、William A. Denny

  DOI：10.1016/j.bmc.2011.12.007

  日期：2012.1

  Quaternary salt analogues based on the DNA minor groove binder and adenine N3 alkylating agent 5-amino-1-(chloromethyl)-1,2-dihydro-3H-benz[e]indole (aminoCBI) show remarkable effects on the body weight of mice (a long-term failure to gain weight relative to matched controls with no loss of appetite or perceptible deterioration in health) following administration of a single (non-toxic) dose between about 0.5-5 mu mol/kg. The nature of the quaternizing group was not important, but a related hydroxyCBI analogue was much less effective. Compounds where the chloro group was replaced by a hydrogen or hydroxy group (thus abrogating DNA alkylating capability) showed no weight control activity. It is speculated, based on other studies, that the marked long-term weight control effect is due to inhibition of bile flow into the intestine and reduced absorption of triglycerides, together with accelerated cell death in spleen and white adipose tissues due to drug accumulation there. This class of compound may serve as interesting tools for further study of these phenomena. (C) 2011 Elsevier Ltd. All rights reserved.
• CYCLOPROPYLINDOLE COMPOUNDS AND THEIR USE AS PRODRUGS
  申请人：AUCKLAND UNISERVICES LIMITED

  公开号：EP0938474B1

  公开（公告）日：2005-11-23
• US6130237A
  申请人：——

  公开号：US6130237A

  公开（公告）日：2000-10-10